A study on cognitive dysfunction improvement of aripiprazole for Japanese schizophrenia patients.
Not Applicable
Completed
- Conditions
- schzophrenia
- Registration Number
- JPRN-UMIN000013765
- Lead Sponsor
- Division of Neuropsychiatry, Department of Brain and Neuroscience, Faculty of Medecine, Tottori University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
The person who has a different mental disease in DSM-4 or DSM-5. A person with strong suicidal ideation and material-dependent past. A person with the past of the disease of brain tissues such as a severe head injury, the cerebrovascular disorder. A person with the past of physically serious medical history. A person with the past of daibetes. A pregnant person or a person with the pregnancy possibility and lactating. The person who uses a long-term acting antiphychotic drug(depot preparation) within three weeks before intervention. The person who is forbidden to use aripiprazole or risperidone on an appended paper.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method neuropsychological test(BACS), assessment of subjective wellbeing(SWNS-J), QOL/evaluztion of social life function(SF-36)
- Secondary Outcome Measures
Name Time Method sympton evaluation(PANSS, CGI), extrapyramidal system side efffect evaluation(DIEPSS), NIRS, ERP, fMRI